GSA Capital Partners LLP Has $189,000 Position in Tricida, Inc. (NASDAQ:TCDA)

GSA Capital Partners LLP lessened its position in Tricida, Inc. (NASDAQ:TCDAGet Rating) by 90.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,983 shares of the company’s stock after selling 222,516 shares during the quarter. GSA Capital Partners LLP’s holdings in Tricida were worth $189,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of TCDA. Deep Track Capital LP acquired a new stake in Tricida in the 4th quarter valued at approximately $22,324,000. Commodore Capital LP acquired a new stake in Tricida in the 4th quarter valued at approximately $11,922,000. Stonehill Capital Management LLC raised its position in Tricida by 540.9% in the 4th quarter. Stonehill Capital Management LLC now owns 916,967 shares of the company’s stock valued at $8,766,000 after buying an additional 773,895 shares during the last quarter. Walleye Capital LLC acquired a new stake in Tricida in the 4th quarter valued at approximately $1,495,000. Finally, Victory Capital Management Inc. acquired a new stake in Tricida in the 1st quarter valued at approximately $994,000.

Tricida Stock Down 0.8 %

TCDA stock opened at $12.49 on Friday. The company has a quick ratio of 5.11, a current ratio of 5.11 and a debt-to-equity ratio of 584.92. The business has a 50 day moving average price of $11.02 and a two-hundred day moving average price of $9.79. The company has a market cap of $695.31 million, a price-to-earnings ratio of -4.61 and a beta of 0.68. Tricida, Inc. has a twelve month low of $4.01 and a twelve month high of $13.85.

Insider Buying and Selling at Tricida

In other Tricida news, major shareholder Brian M. Isern sold 37,339 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $13.42, for a total value of $501,089.38. Following the completion of the transaction, the insider now directly owns 732,675 shares in the company, valued at $9,832,498.50. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Tricida news, major shareholder Venrock Healthcare Capital Par bought 111,111 shares of Tricida stock in a transaction dated Wednesday, June 8th. The stock was bought at an average cost of $9.51 per share, for a total transaction of $1,056,665.61. Following the purchase, the insider now owns 6,344,084 shares of the company’s stock, valued at approximately $60,332,238.84. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Brian M. Isern sold 37,339 shares of Tricida stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $13.42, for a total value of $501,089.38. Following the transaction, the insider now owns 732,675 shares of the company’s stock, valued at $9,832,498.50. The disclosure for this sale can be found here. Insiders purchased a total of 937,282 shares of company stock worth $8,975,160 over the last ninety days. 35.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group dropped their target price on Tricida from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Tuesday, May 24th.

About Tricida

(Get Rating)

Tricida, Inc operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track.

Featured Stories

Want to see what other hedge funds are holding TCDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tricida, Inc. (NASDAQ:TCDAGet Rating).

Institutional Ownership by Quarter for Tricida (NASDAQ:TCDA)

Receive News & Ratings for Tricida Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tricida and related companies with MarketBeat.com's FREE daily email newsletter.